Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 mg | Available to ship TODAYfromMILWAUKEE | $1,080.00 | |
| 500 mg | Check Cart for Availability | $1,970.00 |
About This Item
Linear Formula:
HOOCCH2CH(NHCONH2)COOH
CAS Number:
Molecular Weight:
176.13
UNSPSC Code:
12352106
NACRES:
NA.25
PubChem Substance ID:
EC Number:
213-096-6
Beilstein/REAXYS Number:
1726861
MDL number:
$1,080.00
Available to ship TODAYDetails
Subscriptions are currently unavailable.
Ships Every 4 weeks
Quality Segment
assay
98.0-102.0% (T)
mp
~175 °C (dec.)
format
neat
SMILES string
NC(=O)NC(CC(O)=O)C(O)=O
InChI
1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)
InChI key
HLKXYZVTANABHZ-UHFFFAOYSA-N
Biochem/physiol Actions
Metabolite of pyrimidine biosynthesis, alanine, aspartate and glutamate metabolism.
1 of 1
This Item | |||
|---|---|---|---|
| format neat | format - | format - | format - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 200 |
| assay 98.0-102.0% (T) | assay ≥98.0% (T) | assay ≥99.0% | assay 88.0-92.0% |
| mp ~175 °C (dec.) | mp 170-175 °C (dec.) | mp 195-210 °C (dec.) | mp - |
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
L D Fairbanks et al.
Journal of chromatography. B, Biomedical sciences and applications, 732(2), 487-493 (1999-10-12)
Leflunomide is an immunomodulatory drug which acts by inhibiting dihydroorotic acid dehydrogenase, the fourth enzyme of pyrimidine biosynthesis. We modified our high-performance liquid chromatography method to demonstrate that the principal metabolite in mitogen-stimulated human T-lymphocytes incubated with leflunomide was not
S Vasudevan et al.
Carcinogenesis, 15(11), 2497-2500 (1994-11-01)
Feeding excess orotic acid (OA) in the diet promotes the carcinogenic process in different organs including the liver. A number of metabolic and genetic disorders are associated with increased synthesis of endogenous OA and some of these disorders appear to
R B Wickner
Science (New York, N.Y.), 264(5158), 566-569 (1994-04-22)
A cytoplasmically inherited element, [URE3], allows yeast to use ureidosuccinate in the presence of ammonium ion. Chromosomal mutations in the URE2 gene produce the same phenotype. [URE3] depends for its propagation on the URE2 product (Ure2p), a negative regulator of
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 69037-100MG | 04061832404912 |
| 69037-500MG | 04061832404929 |



